Category

Lupin collaborating with Mylan to commercialise Enbrel

Lupin collaborating with Mylan to commercialise Enbrel

The drug major Lupin has collaborated with the Mylan for commercialising Enbrel for the treatment of Arthritis. Basically, Embrel is an autoimmune disorder drug. The Mylan will make Lupin&rsq...

All set to collaborate with Chinese Pharma market

All set to collaborate with Chinese Pharma market

As per the report which has not been public that encouraged the Indian pharma industry to work with the Chinese but is careful with their intellectual properties. While looking at the Chinese...

Nifty Pharma Update Pharma up on falling rupee

Nifty Pharma Update Pharma up on falling rupee

Thursday morning the pharma stocks were doing great trade whereas the rupee was falling in front of US dollar, the rupee opened with all-time low against the US dollar rupturing 69 level for...

Sun Pharma rising again Lupin and Cipla going down

Sun Pharma rising again Lupin and Cipla going down

This Tuesday till afternoon it was recorded that the Pharma stocked had a mixed trade, the Nifty indexed of pharma was trading 0.17 per cent down at 9,271.

Glenmark and D...

Pharma Industry back on track Becoming fruitful again

Pharma Industry back on track Becoming fruitful again

Indian pharmaceutical sector is now blooming again after plenty of ups and down in past few years handling plenty of regulatory challenges such as recast of FDI policy, patent protection, pri...

NAA questioning consumer goods and pharma organizations regarding GST prices

NAA questioning consumer goods and pharma organizations regarding GST prices

The National Anti-Profiteering Authority (NAA) are questioning around 150 consumer goods and pharma companies regarding their stocks with the distributors and stockists on June 30,2017 were s...

Indian Pharma to enter Profitable Chinese market soon

Indian Pharma to enter Profitable Chinese market soon

Finally, Indian pharma companies are finding a way to enter the world’s second largest pharmaceutical market which is attractive and profitable market of China. Usually it takes 5 years...

Sun Pharma to be the top struggler Pharma stock down

Sun Pharma to be the top struggler Pharma stock down

On Tuesday’s trading session the pharma stocks were down during the last hour, the Biocon was down 1.52 percent, Sun Pharmaceutical industries (down 1.33 percent),Divi’s L...

Previous Page Next Page
1 2 3 4 5 6 7 8 9 10